State-of-the-art behavioral and pharmacological treatments for alcohol use disorderLara A. Ray, Karen Miotto, Spencer Bujarski et al.|The American Journal of Drug and Alcohol Abuse|2018Cited by 137
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysisLara A. Ray, Spencer Bujarski, Daniel Roche et al.|Addiction Biology|2019Cited by 60
The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self‐Administration in the Human LaboratoryReJoyce Green, Lara A. Ray, Spencer Bujarski et al.|Alcoholism Clinical and Experimental Research|2019Cited by 27
Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorderLara A. Ray, Spencer Bujarski, Han Du et al.|Neuropsychopharmacology|2020Cited by 24
Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokersDaniel Roche, Lara A. Ray, Spencer Bujarski et al.|Pharmacology Biochemistry and Behavior|2015Cited by 20